RSV vaccine for people 60+ living in long term care homes, Elder Care Lodges, and some retirement homes
AREXVY is a new vaccine recently approved by Health Canada for the prevention of lower respiratory tract disease (LRTD) caused by RSV in people 60 years of age and older. Following direction from the Ontario Ministry of Health, Ontario is rolling out a publicly funded vaccination program for eligible people (i.e., 60+) living in long term care homes, Elder Care Lodges, and some retirement homes. AREXVY is given as a single dose. A 14-day period is needed between receiving AREXVY and another vaccine, such as COVID-19 and flu.
At this time, the publicly funded AREXVY vaccine is not provided by pharmacies or through Public Health.
While anyone who is 60 years of age or older and not eligible for the publicly funded vaccine can speak to their healthcare provider about receiving the RSV vaccine through private purchase, at this time Hastings Prince Edward Public Health does not have sufficient supply to provide the vaccine to PCPs. When vaccine is available to order, we will provide an update.
More information about the RSV vaccine is available in this fact sheet.
.png?1632837722057)
.png?1578593886679)